Dr Stefanie Parchmann
German Patent Attorney
European Patent Attorney
Chemist
Stefanie Parchmann advises and represents clients from the pharmaceutical, biotechnology, biochemical and chemical industries through all stages of patent prosecution and as well as in patent opposition and appeal proceedings. She also prepares freedom-to-operate and validity opinions.
Having worked for many years as laboratory supervisor and project coordinator in custom manufacturing with a large chemical-pharmaceutical company, Stefanie has first-hand knowledge of the needs of industry with regard to intellectual property protection.
Stefanie lectures on patent law at the Technical University of Munich. As of 01.01.2020 Stefanie Parchmann has been appointed as member of one of the Examination Committees for the European Qualifying Examination for professional representatives (European patent attorneys).
| Since 2020 | Member of one of the Examination Committees of the European Qualifying Examination (EQE) |
Since 2018 | Partner at Maiwald |
| Since 2018 | Lecturer for patent law at the Technical University of Munich |
Since 2008 | Patent attorney at Maiwald |
2004-2007 | Patent attorney trainee at an IP law firm |
1998-2003 | Project and laboratory manager at a chemical-pharmaceutical company |
2008 | Admitted to practice as European patent attorney |
2008 | Admitted to practice as German patent attorney |
2004-2006 | Studied law for patent attorneys at the University of Hagen |
1995-1998 | Doctoral degree in the field of biochemistry from the Ludwig Maximilian University of Munich |
1989-1995 | Studied chemistry and biochemistry at the Ludwig Maximilian University of Munich |
- Patent prosecution and portfolio management
- Filing strategies and drafting patent applications
- Freedom-to-operate and validity analysis
- Opposition and nullity proceedings
- Patent litigation
- Chocolate bunnies cannot be trade marks, Managing Intellectual Property, 01/2011
- Binding effect of EPO decisions, Managing Intellectual Property, 07/2010
- Chocolate trademarks reviewed, Managing Intellectual Property, 03/2010
- Uncertainty over disclaiming positively disclosed embodiments, Managing Intellectual Property, 10/2009
- EPO Enlarged Board to consider dosage regimen claims, Managing Intellectual Property, 07/2008
- London Agreement and Enforcement Directive implemented, Managing Intellectual Property, 01/2008
- Representation of a client before the Enlarged Board of Appeal of the European Patent Office in proceedings G1/16, which led to a hallmark decision on the use of disclaimers in patent claims
- German Patent Attorney Association
- epi
- FICPI
- GRUR
German, English